
Agilent Technologies, Inc. (A)
$
121.38
+0.41 (0.34%)
Key metrics
Financial statements
Free cash flow per share
3.5088
Market cap
34.4 Billion
Price to sales ratio
4.8706
Debt to equity
0.4855
Current ratio
2.0658
Income quality
1.0822
Average inventory
1 Billion
ROE
0.1973
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilent Technologies, Inc. provides application-focused solutions to life sciences, diagnostics, and applied chemical markets globally. The Life Sciences and Applied Markets segment delivers a wide array of analytical instruments and systems, including liquid chromatography systems and components, mass spectrometry systems, gas chromatography systems, and various spectroscopy technologies. The company's innovative approach is evident in its diverse offerings such as cell analysis plate-based assays, flow cytometers, laboratory automation tools, and dissolution testing equipment. Additionally, Agilent incurred an interest expense of $112,000,000.00 reflecting its debt servicing obligations. The gross profit ratio is 0.52 which highlights the efficiency of the company's production and sales operations. Furthermore, the diluted EPS is $4.57 accounting for potential share dilution, while the net income ratio stands at 0.19 demonstrating the company's profitability margin. The reported depreciation and amortization expenses amount to $288,000,000.00 underscoring the wear and tear of its assets. On the diagnostics front, Agilent offers advanced technologies for DNA analysis, including arrays for mutation detection and next-generation sequencing, along with reagents for turbidimetry. In addition, Agilent CrossLab segment delivers essential laboratory supplies and services such as custom chemistries and sample preparation products. The stock is reasonably priced at $126.32 appealing to a broad range of investors. With a high average trading volume of 2,172,196.00 there is strong liquidity in the stock, making it an attractive option for market participants. The company showcases a mid-range market capitalization of $34,411,093,933.00 positioning it as a steady performer within the sector. As a key player in the Medical - Diagnostics & Research industry, Agilent significantly contributes to the overall market landscape, driving innovation and growth within the Healthcare sector. Its comprehensive range of products is marketed through direct sales, distributors, and electronic commerce, ensuring a broad reach in delivering its advanced solutions to a global clientele.
Investing in Agilent Technologies, Inc. (A) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Agilent Technologies, Inc. stock to fluctuate between $96.43 (low) and $160.27 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-02-27, Agilent Technologies, Inc.'s market cap is $34,411,093,933, based on 283,498,879 outstanding shares.
Compared to Eli Lilly & Co., Agilent Technologies, Inc. has a Lower Market-Cap, indicating a difference in performance.
Agilent Technologies, Inc. pays dividends. The current dividend yield is 0.83%, with a payout of $0.26 per share.
To buy Agilent Technologies, Inc. (A) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for A. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Agilent Technologies, Inc.'s last stock split was 699:500 on 2014-11-03.
Revenue: $6,948,000,000 | EPS: $4.59 | Growth: 3.38%.
Visit https://www.agilent.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $179.57 (2021-09-03) | All-time low: $96.43 (2025-04-09).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

zacks.com
A posts Q1 revenue growth and beats sales estimates, but margin pressure and earnings miss send shares lower in pre-market trade.

seekingalpha.com
Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript

zacks.com
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended January 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com
Agilent Technologies (A) came out with quarterly earnings of $1.36 per share, missing the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.31 per share a year ago.

reuters.com
Life sciences firm Agilent Technologies on Wednesday reported first-quarter results that were largely in line with Wall Street estimates on stable demand for its medical tools and equipment used in lab research and diagnostic services.

seekingalpha.com
Bloomberg's 2026 Dividend Focus list highlights 16 'safer' stocks with free cash flow yields exceeding dividend yields, signaling strong dividend sustainability. Top projected net gains for 2026 include PT Telekom at 70.36%, with average net gain estimates of 28.13% across the top ten dividend-focused stocks. Five 'IDEAL' stocks—Continental, Aviva, PT Telekom, Danske Bank, and Western Midstream—offer dividends from $1,000 invested that exceed their single share price.

businesswire.com
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2026 after the stock market closes on Wednesday, Feb. 25. The company will host a conference call to discuss the results at 1:30 p.m. PST the same day. To join the listen-only conference call webcast, click the link on the Events section of Agilent's Investor Relations website. A recording of the call also will be available on the website for 90 days. Abo.

seekingalpha.com
Agilent Technologies, Inc. (A) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

zacks.com
Agilent (A) reported earnings 30 days ago. What's next for the stock?

seekingalpha.com
Bloomberg's 2026 Dividend Focus list highlights 14 ‘safer' stocks with free cash flow yields exceeding dividend yields, signaling potential buy opportunities. Top projected net gainers for 2026 include Marvell Technology (MRVL), Nike (NKE), and PT Telekom Indonesia (TLK), with analyst-estimated gains up to 37.98%. Four ‘IDEAL' stocks—Aviva, Sodexo, Danske Bank, and Western Midstream—offer dividends from $1,000 invested greater than their share price, meeting the dogcatcher ‘watch to buy' threshold.
See all news